North America Aquatic Veterinary Market Forecast to 2030 - Regional Analysis by Type, Diagnostic, Treatment, Species, Diseases Source, and Route of Administration

The North America aquatic veterinary market was valued at US$ 557.03 million in 2022 and is expected to reach US$ 751.98 million by 2030; it is estimated to register a CAGR of 3.8% from 2022 to 2030.

Government Initiatives to Develop Aquaculture Industry Fuel North America Aquatic Veterinary Market

The high demand for seafood and the decreasing annual catch of wild fish are crucial factors that can drive the growth of the aquaculture industry at an exponential rate. Thus, governments are taking initiatives to improve and support the growth of the aquacultural industry. Following are a few recent initiatives:

In February 2021, the Foundation for Food & Agriculture Research (FFAR) raised funds of US$ 790,326 to create a vaccine delivery system to prevent the spread of tilapia lake virus infections and other diseases in the aquaculture sector.

Sea Grant Marine Aquaculture Grant Program: This nationwide competitive grant program, officially known as the "National Marine Aquaculture Initiative (NMAI)," promotes research and demonstration initiatives to advance sustainable marine aquaculture in the US.

In 2022, the USDA National Institute of Food and Agriculture (NIFA) announced a research investment of more than US$ 13 million to investigate new treatments and preventative measures for animal illnesses that cost the global agriculture sector billions of dollars. This included a US$ 625,000 grant to Mississippi State University to assess an antibacterial feed additive that can be used to prevent enteric septicemia in catfish in a secure and useful manner. This study will contribute to developing aquaculture producers' treatment alternatives, improving production efficiency. Thus, an increase in government initiatives to support developments in the aquaculture industry drives the aquatic veterinary market growth.

North America Aquatic Veterinary Market Overview

According to the National Oceanic and Atmospheric Administration, aquaculture generates ~US$ 1.5 billion annually in the US. The World Bank states that the US produced ~448 thousand metric ton of products out of aquaculture. As per the same source, ~5.6 million fishes were produced by the North American aquaculture industry in 2021, of which the US accounted for the production of ~4.7 million, i.e., ~83% of the total regional fish production. According to the Fisheries of the US 2020 report, commercial fishermen in the US landed 8.4 billion pounds valued at US$ 4.7 billion in 2020.

Anglers in the country took nearly 200 million trips for recreational fisheries in 2020. These recreational anglers caught approximately 1 billion fish and released 65% of those caught. The overall recreational harvest was estimated at 344 million fish weighing 353 million pounds. Thus, the flourishing aquaculture industry fuels the growth of the North America aquatic veterinary market in the US.

In September 2020, the Virbac Group acquired various tilapia vaccines from Ictyogroup, an animal health company specializing in R&D biology. The group received rights for the distribution and marketing of these registered, autogenous vaccines worldwide. The two companies had a partnership for the development of new formulations and new vaccines for the Aqua Virbac division. The agreement also allowed the transfer of several employees specialized in technical marketing support and R&D biology from Ictyogroup to Virbac.

In July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC to make a strategic addition to its pharma business. The pharmaceutical business of Zoetis commercializes and develops fish vaccines and offers vaccination and diagnostic services for aquaculture. The acquisition of Fish Vet Group helped Zoetis enhance its diagnostics expertise and testing services, including environmental testing, that Pharmaq's reference lab. Thus, strategic initiatives by various market players in the US aquaculture industry bolster the North America aquatic veterinary market in the US.

North America Aquatic Veterinary Market Segmentation

• The North America aquatic veterinary market is categorized into type, species, diseases source, other route of administration, and country.
• Based on type, the North America aquatic veterinary market is bifurcated diagnostic and treatment. The treatment segment held a larger market share in 2022. The diagnostic segment is further sub segmented into serological, molecular, DNA sequencing, and other diagnostics. The treatment segment is further sub segmented into vaccines, medications, and supplements.
• By species, the North America aquatic veterinary market is segmented into fish, crustaceans, mollusca, and others. The fish segment held the largest market share in 2022.
• Based on diseases source, the North America aquatic veterinary market is segmented into bacterial, viral, parasites, and others. The bacterial segment held the largest market share in 2022.
• In terms of route of administration, the North America aquatic veterinary market is segmented into water medication, medicated feed, and other route of administrations. The water medication segment held the largest market share in 2022.
• By country, the North America aquatic veterinary market is segmented into the US, Canada, and Mexico. The US dominated the North America aquatic veterinary market share in 2022.
• Aquatic Diagnostics Ltd, Ceva Polchem Pvt Ltd, Elanco Animal Health Inc, HIPRA SA, Merck KGaA, Phibro Animal Health Corp, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the North America aquatic veterinary market.

Market Highlights

• Based on type, the North America aquatic veterinary market is bifurcated diagnostic and treatment. The treatment segment held 83.3% market share in 2022, amassing US$ 463.98 million. It is projected to garner US$ 640.98 million by 2030 to register 4.1% CAGR during 2022-2030. The diagnostic segment is further sub segmented into serological, molecular, DNA sequencing, and other diagnostics. The treatment segment is further sub segmented into vaccines, medications, and supplements.
• The fish segment held 54.2% share of North America aquatic veterinary market in 2022, amassing US$ 301.98 million. It is anticipated to garner US$ 428.27 million by 2030 to expand at 4.5% CAGR during 2022-2030.
• The bacterial segment held 55.2% share of North America aquatic veterinary market in 2022, amassing US$ 307.31 million. It is projected to garner US$ 444.27 million by 2030 to expand at 4.7% CAGR from 2022 to 2030.
• In terms of route of administration, the North America aquatic veterinary market is segmented into water medication, medicated feed, and other route of administrations. The water medication segment held 44.2% share of North America aquatic veterinary market in 2022, amassing US$ 245.94 million. It is projected to garner US$ 343.78 million by 2030 to expand at 4.3% CAGR from 2022 to 2030.
• This analysis states that the US captured 83.6% share of North America aquatic veterinary market in 2022. It was assessed at US$ 465.74 million in 2022 and is likely to hit US$ 641.43 million by 2030, registering a CAGR of 4.1% during 2022-2030.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America aquatic veterinary market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the North America aquatic veterinary market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America aquatic veterinary market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.